Lianji Wen
- Co-authors
- Guofang GuanDejun ZhangXuejian ZhaoDe-Qi XuYueting ShaoChunshun JinLifang GaoXingyi Zhang
- Topics
- RNA modifications and cancer (6 papers)RNA Interference and Gene Delivery (5 papers)MicroRNA in disease regulation (5 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lianji Wen
21 papers receiving 450 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 278
- Cancer Research 177
- Oncology 141
- Immunology 65
- Biomedical Engineering 41
Countries citing papers authored by Lianji Wen
This map shows the geographic impact of Lianji Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianji Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianji Wen more than expected).
Fields of papers citing papers by Lianji Wen
This network shows the impact of papers produced by Lianji Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianji Wen. The network helps show where Lianji Wen may publish in the future.
Co-authorship network of co-authors of Lianji Wen
This figure shows the co-authorship network connecting the top 25 collaborators of Lianji Wen. A scholar is included among the top collaborators of Lianji Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianji Wen. Lianji Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 50 | |
| 3 | 11 | |
| 4 | 58 | |
| 5 | 21 | |
| 6 | 8 | |
| 7 | 16 | |
| 8 | 7 | |
| 9 | mTOR inhibitor AZD8055 inhibits proliferation and induces apoptosis in laryngeal carcinoma. | 22 |
| 10 | microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma. | 41 |
| 11 | 1 | |
| 12 | 32 | |
| 13 | 36 | |
| 14 | Small interfering RNA survivin and GRIM-19 co-expression salmonella plasmid inhibited the growth of laryngeal cancer cells in vitro and in vivo. | 11 |
| 15 | [Biological characteristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells]. | 4 |
| 16 | [Research of 10-23 DNAZyme inhibit the expression of eIF4E genes]. | 1 |
| 17 | 31 | |
| 18 | 65 | |
| 19 | [Construction of the nucleic vaccine pVVP3L-18HN and its antitumor effect on human laryngeal carcinoma]. | 3 |
| 20 | Expression and implication of survivin gene in laryngeal carcinoma | 1 |
About Lianji Wen
Lianji Wen is a scholar working on Biotechnology, Cancer Research and Oncology, having authored 22 papers that have together received 455 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), RNA Interference and Gene Delivery (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (177 citations), Oncology (141 citations) and Molecular Medicine (21 citations). Lianji Wen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Guofang Guan, Dejun Zhang, Xuejian Zhao, De-Qi Xu, Yueting Shao, Chunshun Jin, Lifang Gao, Xingyi Zhang, Dan Yu and Yanqing Lu. Their work appears in journals such as Journal of Materials Chemistry B, Otolaryngology and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.